Prognostic significance of minimal residual disease (MRD) in children with high risk acute lymphoblastic leukemia(ALL). A children's oncology group study.

被引：1
|
作者：
Borowitz, MJ
Devidas, M
Bowman, WP
Larsen, E
Pullen, J
Camitta, B
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD USA
[2] Childrens Oncol Grp, Ctr Data, Gainesville, FL USA
[3] Cook Childrens Hosp, Ft Worth, TX USA
[4] Maine Childrens Canc Program, Scarborough, ME USA
[5] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
[6] Midw Childrens Canc Ctr, Milwaukee, WI USA
[7] Childrens Oncol Grp, Arcadia, CA USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.85.85
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
85
引用
收藏
页码：29A / 29A
页数：1
相关论文
共 50 条
  • [1] Minimal residual disease (MRD) in childhood acute lymphoblastic leukemia (ALL) in relapse. A children's oncology group (COG) study.
    Borowitz, MJ
    Devidas, M
    Hunger, SP
    Carroll, WL
    Raetz, E
    BLOOD, 2004, 104 (11) : 96A - 96A
  • [2] Correlation of end-induction minimal residual disease(MRD) in childhood acute lymphoblastic leukemia (ALL) with clinical and biological risk factors. A children's oncology group study.
    Borowitz, MJ
    Shuster, J
    Viswanatha, DS
    Willman, CS
    Montgomery, K
    Pullen, J
    Carroll, AJ
    Camitta, B
    BLOOD, 2001, 98 (11) : 841A - 841A
  • [3] Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
    Borowitz, Michael J.
    Devidas, Meenakshi
    Hunger, Stephen P.
    Bowman, W. Paul
    Carroll, Andrew J.
    Carroll, William L.
    Linda, Stephen
    Martin, Paul L.
    Pullen, D. Jeanette
    Viswanatha, David
    Willman, Cheryl L.
    Winick, Naomi
    Camitta, Bruce M.
    BLOOD, 2008, 111 (12) : 5477 - 5485
  • [4] Improved Post-Induction Chemotherapy Does Not Abrogate Prognostic Significance of Minimal Residual Disease (MRD) for Children and Young Adults with High Risk Acute Lymphoblastic Leukemia (ALL). A Report From Children's Oncology Group (COG) Study AALL0232
    Borowitz, Michael J.
    Wood, Brent L.
    Devidas, Meenakshi
    Loh, Mignon L.
    Raetz, Elizabeth A.
    Salzer, Wanda
    Nachman, James
    Carroll, Andrew J.
    Heerema, Nyla A.
    Gastier-Foster, Julie M.
    Willman, Cheryl L.
    Linda, Stephen B.
    Winick, Naomi
    Hunger, Stephen
    Carroll, William L.
    Larsen, Eric C.
    BLOOD, 2011, 118 (21) : 625 - 626
  • [5] Prognostic significance of minimal residual disease (MRD) in childhood B-precursor ALL and its relation to other risk factors. A Children's Oncology Group (COG) study.
    Borowitz, Michael J.
    Devidas, Meenakshi
    Bowman, W. Paul
    Carroll, William L.
    Chen, I. -Ming
    Harvey, Richard
    Hunger, Stephen
    Martin, Paul L.
    Pullen, Jeanette
    Viswanatha, David
    Willman, Cheryl L.
    Winick, Naomi
    Camitta, Bruce
    BLOOD, 2006, 108 (11) : 69A - 69A
  • [6] Moleculargenetic Detection of Minimal Residual Disease (MRD) in Children with Acute Lymphoblastic Leukemia
    Koehler, R.
    Bartram, C. R.
    KLINISCHE PADIATRIE, 2013, 225 : S40 - S44
  • [7] Prognostic factors for survival after relapsed acute lymphoblastic leukemia (ALL): A Children's Oncology Group (COG) study.
    Rheingold, Susan R.
    Ji, Lingyun
    Xu, Xinxin
    Devidas, Meenakshi
    Brown, Patrick A.
    Gore, Lia
    Winick, Naomi J.
    Carroll, William L.
    Hunger, Stephen
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Bhojwani, Deepa
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study
    Wood, Brent L.
    Devidas, Meenakshi
    Summers, Ryan J.
    Chen, Zhiguo
    Asselin, Barbara
    Rabin, Karen R.
    Zweidler-McKay, Patrick A.
    Winick, Naomi J.
    Borowitz, Michael J.
    Carroll, William L.
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Hunger, Stephen P.
    Dunsmore, Kimberly P.
    Teachey, David T.
    Winter, Stuart S.
    BLOOD, 2023, 142 (24) : 2069 - 2078
  • [9] MONITORING OF MINIMAL RESIDUAL DISEASE AND IT'S SIGNIFICANCE IN DISEASE OUTCOME IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Hazarika, N.
    Dwivedi, P.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S250 - S250
  • [10] A demographic study of the clinical significance of minimal residual disease in children with acute lymphoblastic leukemia
    Levett, D
    Middleton, P
    Cole, M
    Reid, MM
    MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (03): : 365 - 371
12345